Thomas R Sattelberg, Sr

Title: Thomas R Sattelberg, Sr: Innovator in Anti-Viral Compounds

Introduction

Thomas R Sattelberg, Sr is a notable inventor based in Bloomington, IN (US). He has made significant contributions to the field of anti-viral compounds, holding a total of 2 patents. His work focuses on developing compounds that inhibit the growth of various picornaviruses.

Latest Patents

Sattelberg's latest patents include innovative anti-viral compounds. One patent details certain vinyl acetylene benzimidazole compounds that inhibit the growth of picornaviruses, including rhinoviruses, enteroviruses, cardioviruses, polioviruses, coxsackieviruses of the A and B groups, echo virus, and Mengo virus. Another patent presents a series of benzimidazole compounds that serve a similar purpose, also highlighting their utility as intermediates for preparing additional benzimidazole antiviral compounds.

Career Highlights

Sattelberg is currently associated with Eli Lilly and Company, where he continues to advance his research in antiviral therapies. His work has the potential to impact public health significantly by providing new avenues for treatment against viral infections.

Collaborations

Some of his notable coworkers include Shawn Christopher Miller and Frantz Victor, who contribute to the collaborative efforts in research and development at Eli Lilly and Company.

Conclusion

Thomas R Sattelberg, Sr is a dedicated inventor whose work in anti-viral compounds showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against viral diseases.